drugset / Trial / NCT03483545
Menopur And Rekovelle Combination Study
Completed
160 enrolled
Dr François Bissonnette
Create Fertility Center · collabHannam Fertility Centre · collabOlive Fertility Centre · collab
NaSingle-groupOpen-labelOther
Summary
This study proposes to evaluate the effect of adding HP-hMG (Menopur) to follitropin delta in a "mixed protocol" regimen, using an individualized, fixed dose of follitropin delta based on the established algorithm, combined with a variable, adjustable dose of Menopur based on body weight and ovarian reserve.
Timeline
- Start
- 2018-07-17
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Follitropin delta | Protein / enzyme biologic | — | — |
| Subject | Menopur | Protein / enzyme biologic | 75 iu | — |
| Subject | Menopur | Protein / enzyme biologic | 150 iu | — |
| Subject | Menopur | Protein / enzyme biologic | 225 iu | — |